 | • レポートコード：MRC2302C174 • 出版社/出版日：360iResearch / 2023年2月3日 • レポート形態：英語、PDF、225ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：食品 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に927.7億ドルであった世界の栄養補助食品市場規模が、2022年に987.5億ドルになり、2027年まで年平均6.51%で成長して1355億ドルに拡大すると予測しています。本レポートは、栄養補助食品の世界市場について調べ、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、機能別（抗がん、骨・関節健康、心臓健康、糖尿病、その他）分析、製品別（カルシウム、複合栄養補助食品、目健康用サプリメント、魚油・オメガ脂肪酸、その他）分析、処方別（カプセル、液体、粉末、ソフトジェル、錠剤）分析、流通別（オンラインチャネル、薬局・ドラックストア、スーパーマーケット・ハイパーマーケット）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを以下の構成でまとめております。また、American Health、Amway Corporation、Archer-Daniels-Midland Company、ARKOPHARMA Laboratories, Company Limited、Bayer AG、DuPont de Nemours, Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の栄養補助食品市場規模：機能別 - 抗がんにおける市場規模 - 骨・関節健康における市場規模 - 心臓健康における市場規模 - 糖尿病における市場規模 - その他における市場規模 ・世界の栄養補助食品市場規模：製品別 - カルシウムにおける市場規模 - 複合栄養補助食品における市場規模 - 目健康用サプリメントにおける市場規模 - 魚油・オメガ脂肪酸における市場規模 - その他における市場規模 ・世界の栄養補助食品市場規模：処方別 - カプセル型栄養補助食品の市場規模 - 液体型栄養補助食品の市場規模 - 粉末型栄養補助食品の市場規模 - ソフトジェル型栄養補助食品の市場規模 - 錠剤型栄養補助食品の市場規模 ・世界の栄養補助食品市場規模：流通別 - オンラインチャネルの市場規模 - 薬局・ドラックストアチャネルの市場規模 - スーパーマーケット・ハイパーマーケットチャネルの市場規模 ・世界の栄養補助食品市場規模：地域別 - 南北アメリカの栄養補助食品市場規模 アメリカの栄養補助食品市場規模 カナダの栄養補助食品市場規模 ブラジルの栄養補助食品市場規模 … - アジア太平洋の栄養補助食品市場規模 日本の栄養補助食品市場規模 中国の栄養補助食品市場規模 インドの栄養補助食品市場規模 韓国の栄養補助食品市場規模 台湾の栄養補助食品市場規模 … - ヨーロッパ/中東/アフリカの栄養補助食品市場規模 イギリスの栄養補助食品市場規模 ドイツの栄養補助食品市場規模 フランスの栄養補助食品市場規模 ロシアの栄養補助食品市場規模 … - その他地域の栄養補助食品市場規模 ・競争状況 ・企業情報 |
The Global Dietary Supplements Market size was estimated at USD 92.77 billion in 2021 and expected to reach USD 98.75 billion in 2022, and is projected to grow at a CAGR 6.51% to reach USD 135.50 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Dietary Supplements to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Function, the market was studied across Anti-cancer, Bone & Joint Health, Cardiac Health, Diabetes, Energy & Weight Management, Gastrointestinal Health, General Health, and Immunity.
Based on Product, the market was studied across Calcium, Combination Dietary Supplement, Eye Health Supplement, Fish Oil & Omega Fatty Acid, Ginseng, Herbal Supplement, Mineral, Probiotic, Protein, and Vitamin.
Based on Formulation, the market was studied across Capsules, Liquid, Powder, Softgels, and Tablets.
Based on Distribution, the market was studied across Online Channel, Pharmacy & Drug Store, and Supermarket & Hypermarket.
Based on End User, the market was studied across Adult, Children & Infant, Geriatric, and Pregnant Women.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across Arizona, California, Colorado, Florida, Illinois, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, South Carolina, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Dietary Supplements market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Dietary Supplements Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Dietary Supplements Market, including American Health, Amway Corporation, Archer-Daniels-Midland Company, ARKOPHARMA Laboratories, Company Limited, Bayer AG, DuPont de Nemours, Inc., Dymatize Enterprises LLC, FANCL Corporation, Glanbia PLC, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., Nature’s Bounty Co., Nutraceutical International Corporation, Otsuka Holdings Co. Ltd., Pfizer Inc., Sabinsa Corporation, Sanofi S.A., Suntory Holdings Ltd., Taisho Pharmaceutical Co., Ltd., and The Himalaya Drug Company.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Dietary Supplements Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Dietary Supplements Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Dietary Supplements Market?
4. What is the competitive strategic window for opportunities in the Global Dietary Supplements Market?
5. What are the technology trends and regulatory frameworks in the Global Dietary Supplements Market?
6. What is the market share of the leading vendors in the Global Dietary Supplements Market?
7. What modes and strategic moves are considered suitable for entering the Global Dietary Supplements Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Huge Base of Aging Population and Changing Lifestyle
5.1.1.2. Rise of Self-Directed Consumers and Demand Among Athletes
5.1.1.3. Increased Consumer Awareness for Preventative Healthcare
5.1.2. Restraints
5.1.2.1. Noticeable Incidences of a Product Recall and Adverse Reactions of Dietary Supplement without Prescription
5.1.3. Opportunities
5.1.3.1. Inclination towards Plant-Extracted Herbal Products
5.1.3.2. Rising Availability due to Growing E-Commerce Industry
5.1.3.3. Adoption of the Private Label through Innovative Branding and Formulations
5.1.4. Challenges
5.1.4.1. Regulatory Pressure around Manufacturing, Product Safety, and Efficacy Claim
5.2. Cumulative Impact of COVID-19
6. Dietary Supplements Market, by Function
6.1. Introduction
6.2. Anti-cancer
6.3. Bone & Joint Health
6.4. Cardiac Health
6.5. Diabetes
6.6. Energy & Weight Management
6.7. Gastrointestinal Health
6.8. General Health
6.9. Immunity
7. Dietary Supplements Market, by Product
7.1. Introduction
7.2. Calcium
7.3. Combination Dietary Supplement
7.4. Eye Health Supplement
7.5. Fish Oil & Omega Fatty Acid
7.6. Ginseng
7.7. Herbal Supplement
7.8. Mineral
7.9. Probiotic
7.10. Protein
7.11. Vitamin
8. Dietary Supplements Market, by Formulation
8.1. Introduction
8.2. Capsules
8.3. Liquid
8.4. Powder
8.5. Softgels
8.6. Tablets
9. Dietary Supplements Market, by Distribution
9.1. Introduction
9.2. Online Channel
9.3. Pharmacy & Drug Store
9.4. Supermarket & Hypermarket
10. Dietary Supplements Market, by End User
10.1. Introduction
10.2. Adult
10.3. Children & Infant
10.4. Geriatric
10.5. Pregnant Women
11. Americas Dietary Supplements Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Dietary Supplements Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Dietary Supplements Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. American Health
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Amway Corporation
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Archer-Daniels-Midland Company
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. ARKOPHARMA Laboratories, Company Limited
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Bayer AG
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. DuPont de Nemours, Inc.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Dymatize Enterprises LLC
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. FANCL Corporation
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Glanbia PLC
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. GlaxoSmithKline PLC
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Herbalife Nutrition Ltd.
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Nature’s Bounty Co.
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Nutraceutical International Corporation
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Otsuka Holdings Co. Ltd.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Pfizer Inc.
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Sabinsa Corporation
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Sanofi S.A.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Suntory Holdings Ltd.
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Taisho Pharmaceutical Co., Ltd.
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. The Himalaya Drug Company
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing